Pharma Equity A/S : 2024 Q1 Consolidated Interim Report

Consolidated interim report


for the 3 month-period ended 31 March 2024


Pharma Equity Group A/S


Slotsmarken 18, 2.,...

Related Keywords

Portinho ,Distrito De Setubal ,Portugal ,Haarby ,Midtjylland ,Denmark ,Copenhagen ,Køavn ,Sweden ,Portuguese ,Danish ,Troels Peter Troelsen ,Martin Engell Rossen ,Peter Vilmann ,Lars Rosenkrantz Gundorph ,Charlotte Pahl ,Omars Qandeel ,Board Of Directors The Company ,Reponex Pharmaceuticalsas ,Biopharma Holding Ap ,Company Portuguese ,Danske Bank ,European Patent Office ,Company Danish ,Stock Exchange ,Company Announcement No ,Reponex Pharmaceuticals ,High Court ,Analyst Group ,Management Of Pharma Equity Group ,Niels Erik Jespersen Holding Ap ,Ag Equity Research Ab Analyst Group ,Pharma Equity Group ,Equity Group ,Kaas Sels ,Vinding Thomsen ,Vice Chairman ,Executive Management ,Company Announcement ,Wound Healing Drug ,Commercial High Court ,Erik Jespersen Holding Aps ,Entreprise Aps ,Holding Aps ,Rosenkrantz Gundorph ,Board Member ,Peter Troelsen ,Nasdaq Copenhagen ,